Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125380951 | 12538095 | 1 | I | 20160628 | 20160707 | 20160707 | EXP | AU-BAUSCH-BL-2016-016175 | BAUSCH AND LOMB | AMBROSE M, MALLEY R, WARREN S, BEGGS S, SWALLOW O, MCEWAN B. PANDORAEA PNOMENUSA ISOLATED FROM AN AUSTRALIAN PATIENT WITH CYSTIC FIBROSIS. FRONTIERS IN MICROBIOLOGY. 2016;7:692:. | 26.00 | YR | M | Y | 0.00000 | 20160707 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125380951 | 12538095 | 1 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | 0 | 1.5 | G | |||||||||
| 125380951 | 12538095 | 2 | PS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 64052 | 560 | MG | QD | ||||||||
| 125380951 | 12538095 | 3 | SS | TRIMETHOPRIM 1600MG, SULFAMETHOXAZOLE 320MG | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 125380951 | 12538095 | 4 | SS | IMIPENEM | IMIPENEM | 1 | Intravenous (not otherwise specified) | 0 | 1 | G | |||||||||
| 125380951 | 12538095 | 5 | SS | CASPOFUNGIN | CASPOFUNGIN | 1 | Unknown | 0 | 70 | MG | |||||||||
| 125380951 | 12538095 | 6 | SS | CASPOFUNGIN | CASPOFUNGIN | 1 | Unknown | 0 | 50 | MG | |||||||||
| 125380951 | 12538095 | 7 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 0 | 500 | MG | TIW | ||||||||
| 125380951 | 12538095 | 8 | SS | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 12 G OF PIPERACILLIN COMPONENT/24 H | 0 | INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125380951 | 12538095 | 1 | Respiratory tract infection |
| 125380951 | 12538095 | 2 | Respiratory tract infection |
| 125380951 | 12538095 | 3 | Respiratory tract infection |
| 125380951 | 12538095 | 4 | Respiratory tract infection |
| 125380951 | 12538095 | 5 | Respiratory tract infection |
| 125380951 | 12538095 | 7 | Respiratory tract infection |
| 125380951 | 12538095 | 8 | Respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125380951 | 12538095 | LT |
| 125380951 | 12538095 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125380951 | 12538095 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125380951 | 12538095 | 3 | 2013 | 0 | ||
| 125380951 | 12538095 | 4 | 2013 | 0 |